In the TME, IFN-γ promotes anti-tumor immunity not only by activating and recruiting immune cells but also by increasing the expression of major histocompatibility complex (MHC) molecules by tumor cells and directly exerting an anti-proliferative and pro-apoptotic effect on tumor cells. Here, IFNG is linked to neoplasm.